Bioclinic Naturals

Bioclinic Naturals Dolor Ease 120 Veg Capsules

Write a Review
SKU:
20377
UPC:
629022092536
MPN:
BCN-9253
Was: £29.86
Your Price: £23.88
£29.86
You save £5.97

Description

Bioclinic Naturals Dolor Ease 120 Veg Capsules:

Dolor Ease is a comprehensive formula providing some of the best-known natural extracts used in herbal medicine to support joint health and provide temporary relief from joint pain related to osteoarthritis.

  • Comprehensive formula features white willow extract (bark), devil’s claw, Theracurmin curcumin extract, and boswellia extract(Boswellia serrata)
  • Used in herbal medicine for short-term relief of low back pain
  • Traditionally used for the relief of minor joint pain caused by osteoarthritis
  • Contains 30 mg of Theracurmin, the most bioavailable form of curcumin, providing natural antioxidant and anti-inflammatory support
  • Features InflamRelief, a natural source of antioxidants to protect joint tissues

White willow bark contains compounds with anti-inflammatory and analgesic effects which benefits conditions such as low back pain and joint pain associated with osteoarthritis.1

Devil’s claw also contains compounds that participate in down regulating inflammatory cascade, benefiting conditions joint pain associated with osteoarthritis.3

Theracurmin is a highly bioavailable form of curcumin‡, a natural compound with anti-inflammatory and antioxidant properties.4 Standard curcumin is poorly absorbed, but Theracurmin is produced using innovative proprietary technology to create small curcumin particles providing much better bioavailability.

Dolor Ease also features InflamRelief, a source of antioxidants to help protect cells and joint tissues against oxidative damage, as well as boswellia, a plant extract used in herbal medicine to support joint health.

Ingredients:

Medicinal Ingredients Per Veg Capsule:
White Willow Extract bark (15% salicin)
200 mg
Devil’s Claw 1 .8:1 Extract (Harpagophytum procumbens) (secondary root tuber) 
200 mg
Theracurmin® Curcumin* Extract from Turmeric (Curcuma longa) (rhizome) 
30 mg
Boswellia Extract (Boswellia serrata) (gum oleoresin) (60% boswellic acids) 
75 mg
InflamReliefTM Complex:
 
Grape (Vitis vinifera)
Pomegranate (Punica granatum)
Strawberry (Fragaria vesca)
Cranberry (Vaccinium macrocarpon)
Blueberry (Vaccinium corymbosum)
Raspberry (Rubus idaeus)
Bilberry (Vaccinum myrtillus) (standardized to 76% polyphenols) 
50 mg

 

Non-Medicinal Ingredients: Vegetarian capsule (carbohydrate gum [cellulose], purified water), microcrystalline cellulose, croscarmellose sodium, vegetable grade magnesium stearate (lubricant), silica.

Allergens: Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, egg, fish, shellfish, animal products, salt, tree nuts, or GMOs. Suitable for vegetarians/vegans. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.

Recommended Dose:

Recommended Adult Dose: 1–2 capsules 2 times per day or as directed by a health care practitioner . Use for a minimum of 2–3 months to see beneficial effects . For prolonged use, consult a
health care practitioner.

Risk Information:

Contraindications: This product should not be used by anyone who is allergic to ASA or other salicylates, nor by anyone who is pregnant or nursing an infant. Hypersensitivity (e.g., allergy) has been known to occur; if this occurs, discontinue use of this product. Keep out of the reach of children.

Drug Interactions: This product may interact with antiplatelets, blood thinners, anticoagulants, or products containing ASA or other similar derivatives.

References:

1. Chrubasik, S., Eisenberg, E., Balan, E., et al. (2000). Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. American Journal of Medicine, 109(1), 9-14.
2. Mahomed, I. M., &Ojewole, J. A. (2004). Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytotherapy Research, 18(12), 982-989.
3. Warnock, M., McBean, D., Suter, A., et al. (2007). Effectiveness and safety of devil’s claw tablets in patients with general rheumatic disorders. Phytotherapy Research, 21(12), 1228-1233.
4. Sasaki, H., Sunagawa, Y., Takahashi, K., et al. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin, 34(5), 660-665.

‡Scientific scrutiny revealed that Theracurmin was more bioavailable on a milligram-to-milligram basis than other leading? enhanced and regular forms of curcumin. 
?As measured by SPINS 2014 data.

View AllClose

Related Products